COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,757 Articles (22,502 medRxiv, 8,255 bioRxiv)

Most recent first Previous |  Page 432: Articles 4311-4320  | Next

An empirical analysis of lay media coverage on influenza prevention pre- and post-COVID 19: Mask recommendations were previously rare, now ubiquitous.
Prasad, V., Brown, E., Haslam, A.
10.1101/2023.02.14.23285818 — Posted: 2023-02-22
The Equilibrium and Pandemic Waves of COVID-19 in the US
Hu, Z., Hu, X., Xu, T., Zhang, K., Lu, H. H., Zhao, J., Boerwinkle, E., Jin, L., Xiong, M.
10.1101/2023.02.13.23285847 — Posted: 2023-02-21
Longitudinal dynamics of Streptococcus pneumoniae carriage and SARS-CoV-2 infection in households with children.
Miellet, W. R., Mariman, R., Eggink, D., Nicolaie, M. A., van Veldhuizen, J., Pluister, G., Kolodziej, L. M., van Lelyveld, S., Euser, S. M., Sanders, E. A. M., van Houten, M. A., Trzcinski, K.
10.1101/2023.02.20.23286191 — Posted: 2023-02-21
Recognition and Cleavage of Human tRNA Methyltransferase TRMT1 by the SARS-CoV-2 Main Protease
D'Oliviera, A., Dai, X., Mottaghinia, S., Geissler, E. P., Etienne, L., Zhang, Y., Mugridge, J. S.
10.1101/2023.02.20.529306 — Posted: 2023-02-21
A third vaccine dose equalizes the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens
Guibert, N., Trepat, K., Pozzetto, B., Josset, L., Fassier, J.-B., Allatif, O., Saker, K., Brengel-Pesce, K., Walzer, T., Vanhems, P., Trouillet-Assant, S.
10.1101/2023.02.13.23285853 — Posted: 2023-02-21
Efficient Viral Capture and Inactivation from Bioaerosols Using Electrostatic Precipitation.
Preston, H. E., Bayliss, R., Temperton, N. J., Mayora Neto, M., Brewer, J., Parker, A. L.
10.1101/2023.02.19.529105 — Posted: 2023-02-21
Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad and durable systemic and mucosal immune responses
Cheang, N. Y. Z., Tan, P. S., Purushotorman, K., Yap, W. C., Chua, B. Y. L., Tan, K. S., Tullett, K. M., Yeoh, A. Y.-Y., Tan, C. Q. H., Qian, X., Tay, D. J. W., Caminschi, I., Tan, Y. J., MacAry, P. A., Tan, C. W., Lahoud, M. H., Alonso, S.
10.1101/2023.02.21.529344 — Posted: 2023-02-21
Poor sleep quality, insomnia, and short sleep duration before infection predict long-term symptoms after COVID-19
Salfi, F., Amicucci, G., Corigliano, D., Viselli, L., Tempesta, D., D'Atri, A., Ferrara, M.
10.1101/2023.02.13.23285859 — Posted: 2023-02-21
Intrinsic and effective severity of COVID-19 cases infected with the ancestral strain and Omicron BA.2 variant in Hong Kong
Wong, J. Y., Cheung, J. K., Lin, Y., Bond, H. S., Lau, E. H. Y., Ip, D. K. M., Cowling, B. J., Wu, P.
10.1101/2023.02.13.23285848 — Posted: 2023-02-21
Athlete deaths during the COVID-19 vaccination campaign: contextualisation of online information
Binkhorst, M., Goldstein, D. J.
10.1101/2023.02.13.23285851 — Posted: 2023-02-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).